Kevin Mclaughlin - Aug 7, 2024 Form 4 Insider Report for Vericel Corp (VCEL)

Role
Director
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin
Stock symbol
VCEL
Transactions as of
Aug 7, 2024
Transactions value $
-$295,400
Form type
4
Date filed
8/9/2024, 04:05 PM
Previous filing
May 23, 2024
Next filing
Nov 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VCEL Common Stock Options Exercise $18.7K +5K +42.02% $3.74* 16.9K Aug 7, 2024 Direct
transaction VCEL Common Stock Sale -$230K -5K -29.59% $45.92 11.9K Aug 7, 2024 Direct F1
transaction VCEL Common Stock Options Exercise $7.48K +2K +16.81% $3.74* 13.9K Aug 7, 2024 Direct
transaction VCEL Common Stock Sale -$92K -2K -14.39% $45.99 11.9K Aug 7, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCEL Stock Option (Right to Buy) Award $0 +5K $0.00* 0 Aug 7, 2024 Common Stock 5K $3.74 Direct F2, F3
transaction VCEL Stock Option (Right to Buy) Award $0 +2K +18.18% $0.00 13K Aug 7, 2024 Common Stock 2K $3.74 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024.
F2 These options, representing the right to purchase 5,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015.
F3 These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.
F4 These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.